Management of polycythemia vera with hydroxyurea.
Tatarsky
I
I
Department of Hematology, Rambam Medical Center, Faculty of Medicine, Technion, Haifa, Israel.
Sharon
R
R
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011087:Polycythemia Vera / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D006918:Hydroxyurea